Hims & Hers Health, Inc. (HIMS) stock
HIMSNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30191% above fair value
$19.73+0.00 (0.00%)
Close on Nov 13, 2026Market cap $4.60BP/E –Yield –
Hims & Hers Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Hims & Hers Health's ebitda for the twelve months ending Sep 30, 2026 was -$124.74M, down 179.2% year over year. For fiscal 2025 it was $160.12M, up 102.7% from the year before. The highest annual figure on record is $160.12M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $160.12M | +102.7% |
| FY2024 | Dec 31, 2024 | $78.99M | – |
| FY2023 | Dec 31, 2023 | -$19.94M | – |
| FY2022 | Dec 31, 2022 | -$61.22M | – |
| FY2021 | Dec 31, 2021 | -$110.97M | – |
| FY2020 | Dec 31, 2020 | -$14.09M | – |
| FY2019 | Dec 31, 2019 | -$74.15M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$27.94M | -194.8% |
| Q2 FY2026 | Jun 30, 2026 | -$67.72M | -282.1% |
| Q1 FY2026 | Mar 31, 2026 | -$56.37M | -185.2% |
| Q4 FY2025 | Dec 31, 2025 | $27.28M | +10.6% |
| Q3 FY2025 | Sep 30, 2025 | $29.48M | +10.2% |
| Q2 FY2025 | Jun 30, 2025 | $37.19M | +153.4% |
| Q1 FY2025 | Mar 31, 2025 | $66.17M | +412.8% |
| Q4 FY2024 | Dec 31, 2024 | $24.66M | +992.0% |
| Q3 FY2024 | Sep 30, 2024 | $26.76M | – |
| Q2 FY2024 | Jun 30, 2024 | $14.67M | – |
| Q1 FY2024 | Mar 31, 2024 | $12.90M | – |
| Q4 FY2023 | Dec 31, 2023 | $2.26M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.19M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.86M | – |
| Q1 FY2023 | Mar 31, 2023 | -$9.15M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.60M | – |
| Q3 FY2022 | Sep 30, 2022 | -$18.08M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.37M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.18M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.94M | – |
| Q3 FY2021 | Sep 30, 2021 | -$26.12M | – |
| Q2 FY2021 | Jun 30, 2021 | -$16.90M | – |
| Q1 FY2021 | Mar 31, 2021 | -$48.02M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.26M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.02M | – |
| Q2 FY2020 | Jun 30, 2020 | -$767.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.04M | – |
See a number that looks wrong?